Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002785561 | SCV003027510 | uncertain significance | Neutropenia, severe congenital, 2, autosomal dominant | 2022-07-25 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with GFI1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant is present in population databases (rs749555021, gnomAD 0.004%). This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 259 of the GFI1 protein (p.Lys259Arg). |
Ambry Genetics | RCV004064650 | SCV004875055 | uncertain significance | not specified | 2024-03-12 | criteria provided, single submitter | clinical testing | The c.776A>G (p.K259R) alteration is located in exon 4 (coding exon 3) of the GFI1 gene. This alteration results from a A to G substitution at nucleotide position 776, causing the lysine (K) at amino acid position 259 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |